BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


SEARCH JOBS




Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.


 Key Statistics


Email:
Ownership: Public

Web Site: Gilead Sciences, Inc.
Employees: 4,000
Symbol: GILD
 



Industry
Biotechnology






 Company News
France Strikes Deal For Gilead Sciences, Inc. (GILD)'s Hep C Drug Sovaldi 11/21/2014 7:16:33 AM
Knight Therapeutics Sells Priority Review Voucher To Gilead Sciences, Inc. (GILD) For US$125 Million Cash 11/19/2014 7:01:39 AM
Gilead Sciences, Inc. (GILD) Stock Rises After European Commission (EC) Market Authorization For Harvoni 11/18/2014 9:17:45 AM
Gilead Sciences, Inc. (GILD) Prices $4 Billion Of Senior Unsecured Notes 11/13/2014 12:32:02 PM
AbbVie (ABBV) Uses Patents To Ambush Gilead Sciences, Inc. (GILD) 11/13/2014 6:40:25 AM
Gilead Sciences, Inc. (GILD) Announces Phase 2 Data For Investigational All-Oral Regimen Of Sofosbuvir Plus GS-5816 For The Treatment Of Chronic Hepatitis C 11/11/2014 10:42:21 AM
Gilead Sciences, Inc. (GILD) Announces Harvoni Study Results In Chronic Hepatitis C Patients With Advanced Liver Disease And Those Who Failed Prior Treatment 11/11/2014 10:38:21 AM
Hep C King Gilead Sciences, Inc. (GILD)'s Harvoni Prescriptions Are Breaking Records 11/11/2014 6:28:53 AM
Gilead Sciences, Inc. (GILD) Poised To Be One Of The Most Remarkable Growth Stories In Biotech, Says Analyst 11/10/2014 1:32:13 PM
Merck & Co. (MRK)'s Four-Week Hep C Regimen With Gilead Sciences, Inc. (GILD)'s Sovaldi Fails To Deliver 11/10/2014 6:02:09 AM
12345678910...